tm
Seeing Is Believing
tm
Seeing Is Believing
RLMD is currently covered by 1 analysts with an average price target of $22.03. This is a potential upside of $15.04 (215.16%) from yesterday's end of day stock price of $6.99.
Relmada Therapeutics's activity chart (see below) currently has 27 price targets and 40 ratings on display. The stock rating distribution of RLMD is 50% HOLD and 50% BUY.
Analysts average stock forecasts to be materialized ratio is 26.04% with an average time for these price targets to be met of 77 days.
Highest price target for RLMD is $19, Lowest price target is $19, average price target is $19.
Most recent stock forecast was given by UY EAR from MIZUHO on 20-Mar-2026. First documented stock forecast 15-Dec-2019.
Currently out of the existing stock ratings of RLMD, 1 are a HOLD (50%), 1 are a BUY (50%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Mar-2026
$19
$12.01 (171.82%)
$10
15 days ago
(20-Mar-2026)
2/4 (50%)
$12.93 (213.01%)
236
Buy Since 09-Jan-2020
$1
$-5.99 (-85.69%)
1 years 4 months ago
(03-Dec-2024)
2/4 (50%)
$0.37 (58.73%)
158
Buy Since 16-Nov-2021
1 years 4 months 27 days ago
(07-Nov-2024)
0/3 (0%)
$27.69 (124.11%)
Hold Since 17-Sep-2024
$75
1 years 6 months 18 days ago
(17-Sep-2024)
0/2 (0%)
$48.79 (186.15%)
Hold Since 05-Jun-2024
$2
$-4.99 (-71.39%)
1 years 9 months 30 days ago
(05-Jun-2024)
1/2 (50%)
$-0.96 (-32.43%)
182
What is RLMD (Relmada Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on RLMD (Relmada Therapeutics) with a proven track record?
Which analyst has the current lower performing score on RLMD (Relmada Therapeutics) with a proven track record?
Which analyst has the most public recommendations on RLMD (Relmada Therapeutics)?
Which analyst is the currently most bullish on RLMD (Relmada Therapeutics)?
Which analyst is the currently most reserved on RLMD (Relmada Therapeutics)?
